Solid Biosciences Inc.
NASDAQ:SLDB
7.86 (USD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 8.094 | 13.62 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.581 | 2.408 | 58.739 | 3.922 | 2.824 | 1.566 | 0.448 | 0.056 | 0 |
| Gross Profit
| -2.581 | 5.686 | -45.119 | -3.922 | -2.824 | -1.566 | -0.448 | -0.056 | 0 |
| Gross Profit Ratio
| 0 | 0.702 | -3.313 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 76.563 | 78.42 | 58.739 | 64.881 | 94.737 | 57.965 | 39.905 | 20.116 | 4.192 |
| General & Administrative Expenses
| 27.752 | 28.948 | 27.135 | 21.581 | 24.581 | 17.722 | 14.952 | 5.46 | 2.372 |
| Selling & Marketing Expenses
| -2.581 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 25.171 | 28.948 | 27.135 | 21.581 | 24.581 | 17.722 | 14.952 | 5.46 | 2.372 |
| Other Expenses
| 0 | -0.381 | 0.002 | 1.944 | 0.515 | 0.27 | 1.46 | 1.434 | -0.103 |
| Operating Expenses
| 101.734 | 107.368 | 85.874 | 86.462 | 119.318 | 75.687 | 54.857 | 25.576 | 6.564 |
| Operating Income
| -104.315 | -106.452 | -72.254 | -88.406 | -119.318 | -75.687 | -54.857 | -25.576 | -6.564 |
| Operating Income Ratio
| 0 | -13.152 | -5.305 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 8.3 | 20.471 | 0.066 | 0.116 | 2.095 | 0.27 | 1.46 | 1.434 | -0.103 |
| Income Before Tax
| -96.015 | -85.981 | -72.188 | -88.29 | -117.223 | -74.798 | -53.178 | -23.773 | -6.664 |
| Income Before Tax Ratio
| 0 | -10.623 | -5.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -20.471 | -0.064 | 1.828 | -1.58 | 0.889 | -1.279 | -2.603 | -0.287 |
| Net Income
| -96.015 | -65.51 | -72.124 | -90.118 | -115.643 | -74.798 | -52.118 | -21.539 | -6.377 |
| Net Income Ratio
| 0 | -8.094 | -5.295 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -4.83 | -7.7 | -10.13 | -26.03 | -43.05 | -33.73 | -24.26 | -16.8 | -4.97 |
| EPS Diluted
| -4.83 | -7.7 | -10.13 | -26.03 | -43.05 | -33.73 | -24.26 | -16.8 | -4.97 |
| EBITDA
| -101.734 | -107.924 | -69.29 | -80.597 | -116.494 | -75.687 | -54.409 | -25.52 | -6.564 |
| EBITDA Ratio
| 0 | -13.334 | -5.087 | 0 | 0 | 0 | 0 | 0 | 0 |